Article
Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.
Stem cell reports - 14 Apr 2015
Crane Ana M, Kramer Philipp, Bui Jacquelin H, Chung Wook Joon, Li Xuan Shirley, Gonzalez-Garay Manuel L, Hawkins Finn, Liao Wei, Mora Daniela, Choi Sangbum, Wang Jianbin, Sun Helena C, Paschon David E, Guschin Dmitry Y, Gregory Philip D, Kotton Darrell N, Holmes Michael C, Sorscher Eric J, Davis Brian R
Abstract excerpt
Recently developed reprogramming and genome editing technologies make possible the derivation of corrected patient-specific pluripotent stem cell sources-potentially useful for the development of new therapeutic approaches. Starting with skin fibroblasts from patients diagnosed with cystic fibrosis, we derived and characterized induced pluripotent stem cell (iPSC) lines. We then utilized zinc-finger nucleases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
